Kurt Rote

Kurt Rote co-founded Western Oncolytics and led the company through technology licensing from the University of Pittsburgh, seed and Series A fundraising, and Western’s partnership with Pfizer for WO-12. Kurt previously served as Head of Product Development and Marketing at BiognoSYS AG and in Strategy and Business Development roles at Holcim US Inc.

He holds an M.B.A. from the International Institute for Management Development in Switzerland and a B.S.E from Duke University.